Cargando…
DNA Adducts of Decarbamoyl Mitomycin C Efficiently Kill Cells without Wild-Type p53 Resulting from Proteasome-Mediated Degradation of Checkpoint Protein 1
[Image: see text] The mitomycin derivative 10-decarbamoyl mitomycin C (DMC) more rapidly activates a p53-independent cell death pathway than mitomycin C (MC). We recently documented that an increased proportion of mitosene1-β-adduct formation occurs in human cells treated with DMC in comparison to t...
Autores principales: | Boamah, Ernest K., Brekman, Angelika, Tomasz, Maria, Myeku, Natura, Figueiredo-Pereira, Maria, Hunter, Senyene, Meyer, Joel, Bhosle, Rahul C., Bargonetti, Jill |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2010
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907727/ https://www.ncbi.nlm.nih.gov/pubmed/20536192 http://dx.doi.org/10.1021/tx900420k |
Ejemplares similares
-
Decarbamoyl mitomycin C (DMC) activates p53-independent ataxia telangiectasia and rad3 related protein (ATR) chromatin eviction
por: Xiao, Gu, et al.
Publicado: (2015) -
Differential Toxicity of DNA Adducts of Mitomycin C
por: Bargonetti, Jill, et al.
Publicado: (2010) -
Mitomycin C and decarbamoyl mitomycin C induce p53-independent p21(WAF1/CIP1) activation
por: Cheng, Shu-Yuan, et al.
Publicado: (2016) -
A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation
por: Brekman, Angelika, et al.
Publicado: (2011) -
Correction: A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation
por: Brekman, Angelika, et al.
Publicado: (2012)